Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
Clinical trial NCT00525525 · COMPLETED
Trial details
- NCT number
- NCT00525525
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2013-05-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.